REPLIGEN CORPRGEN

Market cap

$8.9B

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenue	-	-	-	-	-	-	-	194	270	366	671	802	639	634
Cost of goods sold	-	-	-	-	-	-	-	87	119	157	279	346	354	360
Research and development	9	10	7	6	6	7	9	16	19	20	34	44	43	43
Selling, general and administrative	9	13	13	17	25	31	52	66	96	120	184	216	218	263
Contingent consideration	-	-	-	2	4	3	-	-	-	-	-	-	-31	3
Total costs and operating expenses	25	51	45	53	70	89	127	168	234	296	503	577	584	670
Income (loss) from operations	-1,107,067	11	23	11	14	16	14	26	36	70	167	225	55	-35
Investment income	161,053	218,604	301,078	309,467	0	0	0	2	5	2	0	7	24	36
Interest expense	-	-	-	-	-	-	-	-	-	-	-	-	-	21
Loss on extinguishment of debt	-	-	-	-	-	-	-	-	-6	-	-0	-	-13	-
Amortization of debt issuance costs	-	-	-	-	-	-	-	-	-	-	-	2	8	2
Other income (expenses)	-	26,403	-110,648	188,000	-0	-1	-1	0	-0	-0	-1	-10	8	-5
Other income (expenses), net	-	-	-	-	-	-	-	-5	-10	-11	-14	-6	10	8
(Loss) income before income taxes	-	-	-	-	13	12	7	21	26	59	154	219	64	-27
Income Tax Expense (Benefit)	15,744	-2,884,631	7	3	4	0	-21	5	5	-1	25	33	23	-2
Net (loss) income	-1,612,625	14	16	8	9	12	28	17	21	60	128	186	42	-26
Basic	-0.05	0.46	0.51	0.25	0.28	0.35	0.74	0.38	0.44	1.14	2.33	3.35	0.75	-0.46
Diluted	-0.05	0.45	0.5	0.25	0.28	0.34	0.72	0.37	0.44	1.11	2.24	3.24	0.74	-0.46
Net income	-1,612,625	14	16	8	9	12	28	17	21	60	128	186	42	-26
Foreign currency translation adjustment	-	2	105,771	-7,743,699	-3	-5	7	-6	-3	17	-19	-18	-3	-15
Comprehensive income (loss)	-	16	16	398,742	7	6	36	11	18	77	109	168	39	-40